Navigation Links
Danaher Completes Offer for Genetix Group plc
Date:1/11/2010

WASHINGTON, Jan. 11 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) announced today that it has acquired and received acceptances in respect of approximately 97% of the currently issued shares of Genetix Group plc (GTX: AIM) in relation to its previously announced offer dated December 18, 2009.

Danaher intends to acquire any common shares of Genetix that remain untendered through the compulsory acquisition provisions of the applicable UK companies legislation.

About Danaher

Danaher (NYSE: DHR), based in Washington. D.C., is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by the Danaher Business System, our 50,000 associates serve customers in more than 125 countries and generated $12.7 billion of revenue in 2008. For more information please visit our website: www.danaher.com.

Statements in this document that are not strictly historical, including statements regarding the acquisition of the untendered shares, may constitute forward looking statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. Information regarding factors that may cause actual results to differ materially from these
'/>"/>

SOURCE Danaher Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Danaher to Present at J.P. Morgan Healthcare Conference
2. Danaher to Present at Robert W. Baird Industrial Conference
3. Danaher Offers to Acquire Genetix Group plc for GBP 50 million pounds Sterling (USD $82 million)
4. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Carrington Completes $8 Million Financing
8. Proteon Therapeutics Completes $12 Million Financing and Hires CFO
9. New Brunswick Scientific Completes Merger Transaction with Eppendorf
10. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
11. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 02, 2015 Shimadzu Scientific Instruments will ... on LCMS and marijuana analysis at the Pittcon 2015 ... to 12 at the Ernest N. Morial Convention Center ... by booth 3121 to discuss laboratory challenges with Shimadzu’s ... proven products help save time, money and effort in ...
(Date:3/2/2015)... British Columbia , March 2, 2015 /PRNewswire/ ... a clinical stage biopharmaceutical company specializing in the ... Craig Schneider , Chief Executive Officer, will ... at VirtualInvestorConferences.com. DATE: Thursday, March 5, ... click the red "register/ watch event now" button ...
(Date:3/2/2015)... March 2, 2015 VG Life Sciences, ... for autoimmune and infectious diseases, announced that the ... an important new composition of matter patent covering ... targeting of CLIP. U.S. Patent ... VG Life Sciences, VG1177, a synthetic peptide which ...
(Date:2/28/2015)... Increasing its efforts to resolve the GMO ... episodes of The GMO TRUTH podcast on both ITunes and ... continues its mission to discover the truth and change the ... “uncover the truth about the GMOs in our food supply,” ... Podcast is an expansion of the documentary/investigative film-making methodology in ...
Breaking Biology Technology:Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 2Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 3InMed Pharmaceuticals to Present Investor Webcast March 5 2VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3The Walk a Mile Project Launches “GMO Truth” Podcast 2
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... Officer of Neurocrine Biosciences, will be presenting at the ...   The live presentation takes place on ... 8:00 a.m. Pacific Time.  The presentation will be webcast ...
... 21, 2012  Thought leaders from the medical community in Europe ... albumin in treating liver disease and sepsis, and in cardiac ... Dialogue – "Albumin in Clinical Fluid Management ." ... participants engaged in a frank and provocative exchange about the ...
... Addario Lung Cancer Medical Institute,s research portfolio is ... platform for venture philanthropy in medical research. The ... president and COO of ALCMI, sister foundation of ... (Logo:  http://photos.prnewswire.com/prnh/20120221/DC56587LOGO ) ...
Cached Biology Technology:Medical Experts Who Participated in CSL Behring's Key Issues Dialogue Prefer Albumin for Fluid Management 2Medical Experts Who Participated in CSL Behring's Key Issues Dialogue Prefer Albumin for Fluid Management 3FasterCures Spotlights Addario Lung Cancer Medical Institute's Innovative Research Programs 2FasterCures Spotlights Addario Lung Cancer Medical Institute's Innovative Research Programs 3
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... cares for the offspring., Apart from the ones he sucks the ... is now creating a stir in the research world. The ... of organising childcare. In this fish species it is the father ... or more females and then looks after in a brood pouch ...
... 2009 Finishing your plate may soon take on a ... Montral School of Industrial Design, has fashioned edible plates that ... phase of her research, which has resulted in a book ... Edible, The Food as Material. "The idea of using ...
... Ga. University of Georgia scientists looking to understand ... found for the first time in plants an inverse ... has implications for diversity not only in plants, but ... published online in this week,s Proceedings of the ...
Cached Biology News:Brooding fishes take up nutrients from their own children 2Plate-eating good: Université de Montréal professor designs edible tableware 2Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3
Mouse monoclonal [X223] to Lamin B1 + B2 - Nuclear Envelope Marker ( Abpromise for all tested applications). entrezGeneID: 4001 SwissProtID: P20700...
... (Human Exonic Evidence Based Oligonucleotide) Genome Set ... ) Genome Set contain a collection of ... constitutively expressed exons, allowing interrogation of thousands ... researchers at Stanford University and UCSF, the ...
odz, odd Oz/ten-m homolog 1 [Source:RefSeq_peptide;Acc:NP_055068] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit polyclonal to FANCE ( Abpromise for all tested applications). entrezGeneID: 2178 SwissProtID: Q9HB96...
Biology Products: